| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b6121dedd894b3f760906b68697d616 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5578
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5585 |
| filingDate |
2006-06-02^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_511e30858f60234904149dbef873079d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea0ebf9b79ba1d20aad9b0272d341675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ce584565f23f4d6f6568c3b374d9e49 |
| publicationDate |
2008-02-13^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1885372-A2 |
| titleOfInvention |
Uses of prostacyclin analogs |
| abstract |
The present invention provides a method for preventing or reducing the risk of cancer or the progression of premalignant dysplasia in a subject having a higher risk factor by administering a therapeutically effective amount of prostacyclin analog. |
| priorityDate |
2005-06-02^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |